Can liquid biopsy-guided EGFR-targeted therapy be a surrogate for the tissue-based standard approach?

被引：0
作者：
Oh, In-Jae [1 ,2 ]
机构：
[1] Chonnam Natl Univ, Med Sch, Dept Internal Med, Gwangju, South Korea
[2] Chonnam Natl Univ, Hwasun Hosp, Lung & Esophageal Canc Clin, 322 Seoyang Ro, Hwasun 58128, Jeonnam, South Korea
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2019年 / 8卷
关键词：
CIRCULATING TUMOR DNA; FACTOR RECEPTOR MUTATIONS; CELL LUNG-CANCER; PHASE-III; GEFITINIB; 1ST-LINE; PREDICTOR; ERLOTINIB;
D O I：
10.21037/tlcr.2019.06.03
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S351 / S354
页数：4
相关论文
共 21 条
[1]   Epidermal Growth Factor Receptor Mutations in Plasma DNA Samples Predict Tumor Response in Chinese Patients With Stages IIIB to IV Non-Small-Cell Lung Cancer [J].
Bai, Hua ;
Mao, Li ;
Wang, Hang Shu ;
Zhao, Jun ;
Yang, Lu ;
An, Tong Tong ;
Wang, Xin ;
Duan, Chun Jian ;
Wu, Na Mei ;
Guo, Zhi Qing ;
Liu, Yi Xu ;
Liu, Hong Ning ;
Wang, Ye Yu ;
Wang, Jie .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (16) :2653-2659
[2]   Application of Cell-free DNA Analysis to Cancer Treatment [J].
Corcoran, Ryan B. ;
Chabner, Bruce A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (18) :1754-1765
[3]   Liquid biopsy: monitoring cancer-genetics in the blood [J].
Crowley, Emily ;
Di Nicolantonio, Federica ;
Loupakis, Fotios ;
Bardelli, Alberto .
NATURE REVIEWS CLINICAL ONCOLOGY, 2013, 10 (08) :472-484
[4]   Gefitinib Treatment in EGFR Mutated Caucasian NSCLC Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status [J].
Douillard, Jean-Yves ;
Ostoros, Gyula ;
Cobo, Manuel ;
Ciuleanu, Tudor ;
Cole, Rebecca ;
McWalter, Gael ;
Walker, Jill ;
Dearden, Simon ;
Webster, Alan ;
Milenkova, Tsveta ;
McCormack, Rose .
JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (09) :1345-1353
[5]   Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non-Small-Cell Lung Cancer in Asia (IPASS) [J].
Fukuoka, Masahiro ;
Wu, Yi-Long ;
Thongprasert, Sumitra ;
Sunpaweravong, Patrapim ;
Leong, Swan-Swan ;
Sriuranpong, Virote ;
Chao, Tsu-Yi ;
Nakagawa, Kazuhiko ;
Chu, Da-Tong ;
Saijo, Nagahiro ;
Duffield, Emma L. ;
Rukazenkov, Yuri ;
Speake, Georgina ;
Jiang, Haiyi ;
Armour, Alison A. ;
To, Ka-Fai ;
Yang, James Chih-Hsin ;
Mok, Tony S. K. .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (21) :2866-2874
[6]   Are liquid biopsies a surrogate for tissue EGFR testing? [J].
Goldman, J. W. ;
Noor, Z. S. ;
Remon, J. ;
Besse, B. ;
Rosenfeld, N. .
ANNALS OF ONCOLOGY, 2018, 29 :I38-I46
[7]   Feasibility of re-biopsy and EGFR mutation analysis in patients with non-small cell lung cancer [J].
Kim, Tae-Ok ;
Oh, In-Jae ;
Kho, Bo Gun ;
Park, Ha Young ;
Chang, Jin Sun ;
Park, Cheol-Kyu ;
Shin, Hong-Joon ;
Lim, Jung-Hwan ;
Kwon, Yong-Soo ;
Kim, Yu-Il ;
Lim, Sung-Chul ;
Kim, Young-Chul ;
Choi, Yoo-Duk .
THORACIC CANCER, 2018, 9 (07) :856-864
[8]   Evaluation of epidermal growth factor receptor mutation status in serum DNA as a predictor of response to gefitinib (IRESSA) [J].
Kimura, H. ;
Suminoe, M. ;
Kasahara, K. ;
Sone, T. ;
Araya, T. ;
Tamori, S. ;
Koizumi, F. ;
Nishio, K. ;
Miyamoto, K. ;
Fujimura, M. ;
Nakao, S. .
BRITISH JOURNAL OF CANCER, 2007, 97 (06) :778-784
[9]   Detection of epidermal growth factor receptor mutations in circulating tumor DNA: reviewing BENEFIT clinical trial [J].
Malapelle, Umberto ;
Raez, Luis E. ;
Jose Serrano, Maria ;
Rolfo, Christian .
JOURNAL OF THORACIC DISEASE, 2018, 10 (12) :6388-6391
[10]   Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review [J].
Merker, Jason D. ;
Oxnard, Geoffrey R. ;
Compton, Carolyn ;
Diehn, Maximilian ;
Hurley, Patricia ;
Lazar, Alexander J. ;
Lindeman, Neal ;
Lockwood, Christina M. ;
Rai, Alex J. ;
Schilsky, Richard L. ;
Tsimberidou, Apostolia M. ;
Vasalos, Patricia ;
Billman, Brooke L. ;
Oliver, Thomas K. ;
Bruinooge, Suanna S. ;
Hayes, Daniel F. ;
Turner, Nicholas C. .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (16) :1631-+
123